Board of Directors & Board committees

Anders Ekblom

Chairman of the Board

Chairman of the Board since 2021
Chairman of the Remuneration Committee
Born 1954

Education: M.D., Board certified in Anesthesiology and Intensive Care, D.D.S., Associate Professor in Physiology, Karolinska Institutet

Other current activities: Chairman of the Board of Alligator Bioscience AB, Atrogi AB, and Elypta AB, Member of the Board of AnaMar AB, Flerie Invest AB, Mereo BioPharma Goup Plc, and Deputy director of Xspray Pharma Futurum AB

Holdings: 4,500 shares, 13 214 warrants (LTIP 2021/2026)

Independent in relation to the Company and its management, but not in relation to major shareholders

Anders Bladh

Board member since 2021

Member of the Remuneration Committee
Born 1958

Education: Bachelor of Science in Business Administration and Economics, University of Uppsala

Other current activities: Owner, member of the Board, as well as CEO of Intervalor AB, Ribbskottet AB, and Rimturs AB, as well as member of the Board of DistIT AB

Holdings: 249,700 shares, and 4,100,000 shares via company Ribbskottet AB

Independent in relation to the Company and its management, but not in relation to major shareholders.

Maris Hartmanis

Board member

Board member since 2015
Chairman of the Audit Committee
Born 1953

Education: Ph.D. in Biochemistry and Associate Professor, Kungliga Tekniska Högskolan (Royal Institute of Technology)

Other current activities: CEO and Chairman of the research foundation FINGERS Brain Health Institute and Affiliated Professor, Karolinska Institutet

Previous assignments (the recent 5 years): CEO and Chairman of the Board of Hartmanis & Partners AB, Board member of BioLamina, Xbrane Biopharma AB, and Applied Photophysics Ltd., England

Holdings: 38,159 shares

Independent in relation to the Company and its management and in relation to major shareholders

Torbjörn Koivisto

Board member

Board member since 2017
Member of the Remuneration Committee
Born 1969

Education: Master of Laws (LL.M.), University of Uppsala

Other current activities: Other current activities: Board member of Cinclus Pharma Holding AB, Cinclus Pharma AB, and IARU Institutet för Affärsjuridisk Rådgivning I Uppsala AB, as well as deputy of RJC Roger Johansson Consulting AB, and Virdings Allé Invest AB

Holdings: 10,000 shares via company (IARU)

Independent in relation to the Company and its management and in relation to major shareholders

Christine Lind

Board member

Board member since 2019
Member of the Audit Committee
Born 1974

Education: Bachelors in Science in Finance and information Systems, New York University, Masters in Business Administration in Finance and Management, Columbia Business School

Other current activities: Other current activities: VP Commercial of NDA Group AB, chairman and CEO of Lind Growth Strategy AB, chairman of the board in Mendus AB and deputy board member of Shinka Life Sciences AB

Holdings: 7,368 shares

Independent in relation to the Company and its management and in relation to major shareholders

Robert Molander

Board member

Board member since 2022
Resides in the USA
Born 1965

Education: MBA from Washington University and two bachelor’s degrees from Miami University in Economics and International Studies

Other current activities: CEO of Stratfox Healthcare Group LLC

Holdings: 10,000 shares

Independent in relation to the Company and its management and in relation to major shareholders

Carl-Johan Spak

Board member

Board member since 2015
Member of the Audit Committee
Born 1956

Education: Dr. of Odontology, Degree in Dentistry, Karolinska Institutet

Other current activities: Board member of Provell Pharmaceuticals LLC, Atrogi AB, EpiEndo ehf, KAHR Medical Ltd., Pharmacolog
i Uppsala AB, Lipum AB, and Symcel AB, and deputy in Buzzard Pharmaceuticals AB

Holdings: None

Independent in relation to the Company and its management and in relation to major shareholders

Board committees